Publications by authors named "Roberta Pirolo"

Claim this Profile
C
Can Nurse-Based Management Screening Ensure Adequate Outcomes in Patients With Gestational Diabetes? A Comparison of 2 Organizational Models.
Laura Nollino, Maria Lisa Marcon, Edward Kiwanuka, Michela Merlotto-Cazziola, Maria Sambataro, Roberta Pirolo

Qual Manag Health Care· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study.
Ylenia Ingrasciotta, Francesco Giorgianni, Ilaria Marcianò, Jenny Bolcato, Roberta Pirolo

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-practice thromboprophylaxis in atrial fibrillation.
Paola Deambrosis, Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo, Giulia Franchin

Acta Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.
Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni, Jenny Bolcato, Alessandro Chinellato, Roberta Pirolo

BioDrugs· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.
Ylenia Ingrasciotta, Francesco Giorgianni, Jenny Bolcato, Alessandro Chinellato, Roberta Pirolo

BioDrugs· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis